Suriname vs United States of America: Tuberculosis treatment success rate
Suriname
72.0%
in 2023
United States of America
72.0%
in 2022
Suriname rank
154th
United States of America rank
154th
Tuberculosis treatment success rate over time
- Suriname
- United States of America
How they compare
Suriname currently reports 72.0% against 72.0% in United States of America, a difference of 0.0%.
The two have swapped places 3 times across 23 shared years of data; in 1995 it was United States of America ahead.
Suriname ranks 154th and United States of America ranks 154th of 206 countries.
United States of America has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Suriname | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 51.3% | 79.7% | 28.3% | United States of America |
| 2000s | 63.7% | 80.6% | 16.9% | United States of America |
| 2010s | 73.3% | 79.2% | 5.9% | United States of America |
| 2020s | 73.3% | 74.0% | 0.7% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Suriname or United States of America?
- Suriname, at 72.0% against 72.0% in United States of America as of 2023.
- What is the difference in tuberculosis treatment success rate between Suriname and United States of America?
- 0.0%, with Suriname ahead.
- How many years of comparable data are there for Suriname and United States of America?
- 23 years are reported by both, from 1995 to 2022.
- How do Suriname and United States of America rank globally for tuberculosis treatment success rate?
- Suriname ranks 154th and United States of America ranks 154th of 206 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.